VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 83 filers reported holding VAXCYTE INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,453,446 | -15.1% | 1,342,751 | -16.8% | 2.28% | -2.1% |
| Q2 2023 | $80,609,253 | +83.8% | 1,614,122 | +38.0% | 2.33% | +80.2% |
| Q1 2023 | $43,851,600 | -21.8% | 1,170,000 | 0.0% | 1.30% | -17.8% |
| Q4 2022 | $56,101,500 | +234.2% | 1,170,000 | +37.6% | 1.58% | +642.9% |
| Q1 2021 | $16,787,000 | -25.7% | 850,000 | 0.0% | 0.21% | -12.4% |
| Q4 2020 | $22,585,000 | -46.2% | 850,000 | 0.0% | 0.24% | -60.5% |
| Q3 2020 | $41,973,000 | +56.2% | 850,000 | 0.0% | 0.61% | +40.9% |
| Q2 2020 | $26,869,000 | – | 850,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $82,124,000 | 28.36% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $37,277,000 | 21.71% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,405,421 | $27,757,000 | 8.90% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $45,614,000 | 3.66% |
| RA Capital Management | 3,865,808 | $76,350,000 | 1.15% |
| TPG Group Holdings (SBS) Advisors, Inc. | 4,558,475 | $90,030,000 | 1.05% |
| Soleus Capital Management, L.P. | 293,650 | $5,800,000 | 1.04% |
| Opaleye Management Inc. | 357,800 | $7,067,000 | 1.04% |
| SABBY MANAGEMENT, LLC | 178,992 | $3,535,000 | 0.69% |
| Penn Mutual Asset Management, LLC | 22,227 | $439,000 | 0.50% |